Assessment of in vitro sensitivity of Plasmodium vivax fresh isolates

Asian Pacific Journal of Tropical Biomedicine

Volumn 1, Issue 1, 2011, Pages 49-53

  Muhamad, Poonuch ^a   Chacharoenkul, Wanna ^a   Rungsihirunrat, Kanchana ^b   Ruengweerayut, Ronnatrai ^c   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAE SOT GENERAL HOSPITAL   (Thailand)

Author keywords

Antifolate; Antimalarial drug; Chloroquine; Fresh isolate; In vitro sensitivity; Malaria; Plasmodium vivax; Schizont maturation inhibition assay; Standard regimen; SYBR Green I assay

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; CHLOROQUINE; ANTIMALARIAL AGENT; ORGANIC COMPOUND; SYBR GREEN I;

ANALYTIC METHOD; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; IC 50; INTERMETHOD COMPARISON; NONHUMAN; PARASITE ISOLATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PREVALENCE; PRIORITY JOURNAL; SCHIZONT MATURATION ASSAY; SYBR GREEN I ASSAY; DRUG EFFECTS; DRUG SENSITIVITY; IC50; ISOLATION AND PURIFICATION; PARASITEMIA; PARASITOLOGY; SCHIZONT;

ANTIMALARIALS; CHLOROQUINE; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, VIVAX; ORGANIC CHEMICALS; PARASITEMIA; PARASITIC SENSITIVITY TESTS; PLASMODIUM VIVAX; SCHIZONTS;

EID: 82455223706     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(11)60067-1     Document Type: Article

References (18)

1. Moonen B, Cohen JM, Tatem AJ, Cohen J, Hay SI, Sabot O, et al. A framework for assessing the feasibility of malaria elimination. Malar J 2010, 9:322-328.
2. Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 2010, 8(4):272-280.
3. Na-Bangchang K, Karbwang J Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. Fundam Clin Pharmacol 2009, 23(4):387-409.
4. Baird JK Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev 2009, 22(3):508-534.
5. Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, Powell RD Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg 1968, 17(5):661-671.
6. Udomsangpetch R, Kaneko O, Chotivanich K, Sattabongkot J Cultivation of Plasmodium vivax. Trends Parasitol 2008, 24(2):85-88.
7. Tasanor O, Noedl H, Na-Bangchang K, Congpuong K, Sirichaisinthop J, Wernsdorfer WH An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Trop 2002, 83(1):49-61.
8. Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother 2003, 47(1):170-173.
9. Noedl H, Wongsrichanalai C, Wernsdorfer WH Malaria drug sensitivity testing: new assays, new perspectives. Trends Parasitol 2003, 19(4):175-181.
10. Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans R Soc Trop Med Hyg 2008, 102(4):346-351.
11. Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, et al. Novel, rapid, and inexpensive cell based quantification of antimalarial drug efficacy. Antimicrob Agents Chemother 2004, 48(5):1807-1810.
12. Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, et al. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother 2008, 52(3):1040-1045.
13. Tasanor O, Ruengweerayut R, Sirichaisinthop J, Congpuong K, Wernsdorfer WH, Na-Bangchang K Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. Trans R Soc Trop Med Hyg 2006, 100(5):410-418.
14. Hastings MD, Maguire JD, Bangs MJ, Zimmerman PA, Reeder JC, Baird JK, et al. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. Antimicrob Agents Chemother 2005, 49(2):733-740.
15. Rungsihirunrat K, Na-Bangchang K, Hawkins VN, Mungthin M, Sibley CH Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand. Am J Trop Med Hyg 2007, 76(6):1057-1065.
16. Japrung D, Leartsakulpanich U, Chusacultanachai S, Yuthavong Y Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination. Antimicrob Agents Chemother 2007, 51(12):4356-4360.
17. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 2004, 48(5):1803-1806.
18. Kosaisavee V, Suwanarusk R, Nosten F, Kyle DE, Barrends M, Jones J, et al. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates. Exp Parasitol 2006, 114(1):34-39.